GoKawiilStudy identifies transcription pause and elongation factors as regulators of antibody hypermutation
Researchers studied how somatic hypermutation, the process that diversifies antibody genes in B cells, is controlled by proteins that regulate RNA polymerase pausing and elongation, including NELF and the Integrator complex subunit INTS8. Using mouse models with Nelfb deleted specifically in germinal center B cells, alongside Ramos and CH12F3 B-cell lines, they mapped how these transcriptional regulators influence mutation patterns in immunoglobulin genes.
GoKawiil's interpretation of the reporting above, not reported fact.
Somatic hypermutation is central to the immune system's ability to produce high-affinity antibodies, and understanding its molecular control could inform research into antibody engineering, vaccine design, and B-cell cancers linked to mutation errors. By tying general transcription machinery components like NELF and Integrator to this specialized DNA-editing process, the findings suggest broader mechanistic links between transcription dynamics and genome-targeted mutagenesis than previously appreciated.
- NELF, via conditional knockout in mouse germinal center B cells, was shown to affect somatic hypermutation.
- A new antibody against INTS8, a subunit of the Integrator complex, was developed and used to probe its role in mutation regulation.
- Human Ramos and CH12F3 B-cell lines, standard models for hypermutation research, were used alongside mouse genetics to validate findings.
Source: nature.com — Wu, 2026-09-30
Published there as: “Transcription pause and elongation regulators mediate somatic hypermutation”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.